K-RAS ONCOGENE ACTIVATION IN ADENOCARCINOMA OF THE HUMAN PANCREAS - ASTUDY OF 82 CARCINOMAS USING A COMBINATION OF MUTANT-ENRICHED POLYMERASE CHAIN-REACTION ANALYSIS AND ALLELE-SPECIFIC OLIGONUCLEOTIDE HYBRIDIZATION
Rh. Hruban et al., K-RAS ONCOGENE ACTIVATION IN ADENOCARCINOMA OF THE HUMAN PANCREAS - ASTUDY OF 82 CARCINOMAS USING A COMBINATION OF MUTANT-ENRICHED POLYMERASE CHAIN-REACTION ANALYSIS AND ALLELE-SPECIFIC OLIGONUCLEOTIDE HYBRIDIZATION, The American journal of pathology, 143(2), 1993, pp. 545-554
We examined 82 surgically resected or biopsied, formalin-fixed, paraff
in-embedded primary adenocarcinomas of the pancreas for the presence o
f activating point mutations in codon 12 of the K-ras oncogene. Mutati
ons were detected using primer-mediated, mutant-enriched, polymerase c
hain reaction-restriction fragment length polymorphism analysis and ch
aracterized further by allele-specific oligonucleotide hybridization.
This combination of mutant-enriched polymerase chain reaction-restrict
ion fragment length polymorphism analysis and allele-specific oligonuc
leotide hybridization results in a rapid and sensitive characterizatio
n of the mutations in codon 12 of K-ras. Sixty-eight (83%) of the 82 c
arcinomas examined harbored a point mutation. Of the 68 mutations, 33
(49%) were guanine to adenine transitions, 27 (39%) were guanine to th
ymine transversions, and eight (12%) were guanine to cytosine transver
sions. Mutations were found in carcinomas of the bead (61 of 75, 81%)
as well as in carcinomas of the body or tail (seven of seven, 100%) of
the pancreas. The overall prevalence of K-ras point mutations in aden
ocarcinomas of the pancreas obtained from patients who smoked cigarett
es at some point during their lives (88%; 86% in current smokers and 8
9% in ex-smokers) was greater than that seen in pancreatic adenocarcin
omas from patients who never smoked cigarettes (68%, P = 0.046). The p
resence of K-ras point mutations did not correlate with tumor ploidy,
tumor proliferating index, or patient survival. These results demonstr
ate that primer-mediated, mutant-enriched polymerase chain reaction-re
striction fragment length polymorphism analysis combined with allele-s
pecific oligonucleotide hybridization can be used to detect and charac
terize mutations in codon 12 of the K-ras oncogene in formalin-fixed,
paraffin-embedded tissues, and the results confirm that activating poi
nt mutations in codon 12 of the K-ras oncogene occur frequently in ade
nocarcinomas of the pancreas.